Buscar
Mostrando documentos 61-70 de 2296
Sofosbuvir terminated RNA is more resistant to SARS‐CoV‐2 proofreader than RNA terminated by Remdesivir
SARS-CoV-2 is responsible for COVID-19, resulting in the largest pandemic in over a hundred years.
After examining the molecular structures and activities of hepatitis C viral inhibitors and comparing
hepatitis C virus ...
Cardiac involvement in recovered COVID-19 patients identified by magnetic resonance imaging
Objective: To evaluate cardiac involvement in recovered COVID-19 patients using cardiac
MRI.
Background: Myocardial injury caused by COVID-19 was previously reported in
hospitalized patients. It is unknown if there is ...
Paromomycin: a potential dual targeted drug effectively inhibits both Spike (S1) and Main Protease of COVID-19
Objectives: With increase in number of people suffering from COVID-19, there is a dire need to
look for effective remedies against this pandemic. Drug repurposing seems to be the solution for
current situation.
Methods: ...
The Unexpected Risks of COVID-19 on Asthma Control in Children
Much is being learned about clinical outcomes for adult
COVID-19 patients with underlying chronic conditions;
however, there is less coverage on how the COVID-19 pandemic
impacts the management of chronic medical ...
COVID-19 and myocarditis: What do we know so far?
COVID-19 has been declared a global pandemic by the World Health
Organization and is responsible for hundreds of thousands of deaths
worldwide. COVID-19 is caused by SARS-CoV-2, and common clinical
symptoms include ...
Acute exacerbation of interstitial lung disease as a sequela of COVID-19 pneumonia
Interstitial lung disease (ILD) is a heterogeneous group of disorders characterized by
dyspnea and bilateral infiltrations of the lung. While some cases are idiopathic (e.g., idiopathic
pulmonary fibrosis), others are ...